Editorial response: Hyperlactatemia and hepatic steatosis as features of mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors

被引：59
作者：
Brinkman, K [1 ]
机构：
[1] Onze Lieve Vrouwe Gasthuis, Dept Internal Med, NL-1091 HA Amsterdam, Netherlands
来源：
CLINICAL INFECTIOUS DISEASES | 2000年 / 31卷 / 01期
关键词：
D O I：
10.1086/313921
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：167 / 169
页数：3
相关论文
共 13 条
  • [1] Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy
    Brinkman, K
    Smeitink, JA
    Romijn, JA
    Reiss, P
    [J]. LANCET, 1999, 354 (9184) : 1112 - 1115
  • [2] Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway
    Brinkman, K
    ter Hofstede, HJM
    Burger, DM
    Smeitinkt, JAM
    Koopmans, PP
    [J]. AIDS, 1998, 12 (14) : 1735 - 1744
  • [3] BRINKMAN K, 1999, AIDS REV, V1, P141
  • [4] FORTGANG IS, 1995, AM J GASTROENTEROL, V90, P1433
  • [5] Fromenty Bernard, 1997, Journal of Hepatology, V26, P13, DOI 10.1016/S0168-8278(97)82328-8
  • [6] MITOCHONDRIAL TOXICITY OF ANTIVIRAL DRUGS
    LEWIS, W
    DALAKAS, MC
    [J]. NATURE MEDICINE, 1995, 1 (05) : 417 - 422
  • [7] Hyperlactatemia and hepatic abnormalities in 10 human immunodeficiency virus-infected patients receiving nucleoside analogue combination regimens
    Lonergan, JT
    Behling, C
    Pfander, H
    Hassanein, TI
    Mathews, WC
    [J]. CLINICAL INFECTIOUS DISEASES, 2000, 31 (01) : 162 - 166
  • [8] LACTIC-ACIDOSIS
    MADIAS, NE
    HARRINGTON, JT
    CANZANELLO, VJ
    TANNEN, RL
    LEVEY, AS
    PERRONE, RD
    [J]. KIDNEY INTERNATIONAL, 1986, 29 (03) : 752 - 774
  • [9] MAULIN L, 1999, 39 INT C ANT AG CHEM
  • [10] Zidovudine-induced fatal lactic acidosis and hepatic failure in patients with acquired immunodeficiency syndrome: Report of two patients and review of the literature
    Sundar, K
    Suarez, M
    Banogon, PE
    Shapiro, JM
    [J]. CRITICAL CARE MEDICINE, 1997, 25 (08) : 1425 - 1430
12